We value your privacy

We use cookies to analyze site usage and improve your experience. You can accept all, reject non-essential, or customize. See our Privacy Policy.

Benefits · 7 min read

Paying per participant vs per employee: how GLP-1 program pricing works

By Kevin Wolfe, Founder & CEO

Reviewed by Kindr Health Clinical Team

Published · Updated

See how billing denominators change a GLP-1 budget, with side-by-side arithmetic and contract questions for finance teams.

Two GLP-1 proposals can use the same words—“per employee per month”—and still mean different things. Finance needs the denominator, activation rule and scope before comparing the headline rates.

The two most common models are PEPM, based on an eligible-employee census, and per active participant, based on people who actually enroll and meet the contract’s activity definition.

What does PEPM mean?

PEPM stands for per employee per month. The agreement should define which employees count: all employees, benefits-eligible employees or another class.

For example, a $20 PEPM fee for 500 eligible employees is $10,000 per month. If only 25 people use the service, the fee still follows the eligible census unless the contract says otherwise. PEPM can support predictable budgeting and broad access, but utilization does not usually change the denominator.

What does per active participant mean?

Per-active-participant pricing follows enrolled users. Kindr Benefits models $199 per active enrolled participant per month, with medication separate. At 25 active participants, the monthly program fee is $4,975. At 50, it is $9,950.

This can align spending with use, but the contract must define “active.” Ask about new enrollment, pauses, leaves, departures, proration, minimums and reactivation. Without those answers, the label is incomplete.

How do the models compare in one scenario?

Imagine 500 eligible employees and 25 active participants:

ModelRateDenominatorMonthly fee
PEPM illustration$20500 eligible employees$10,000
Active-participant model$19925 active participants$4,975

This is arithmetic, not a claim that one vendor offers better value. The $20 and $199 rates may buy different services, and medication is not included in either example unless the written scope says so.

How should employee cost sharing appear?

Show the employer contribution and employee share separately. If an employer pays $149 of a $199 active-participant fee, the employee share is $50 per month. Medication, plan cost sharing or third-party pharmacy charges may be additional.

HSA or FSA funds may be used for qualified expenses, but the administrator determines eligibility and documentation. Do not turn a cost-sharing calculation into an eligibility promise.

Which contract questions prevent surprises?

Ask whether there is a minimum census or participant count, a setup fee, a platform fee, a required term or an early-termination charge. Confirm what happens to the invoice when participation changes mid-month.

Ask which services are included: clinical visits, coaching, follow-up, medication, shipping, reporting and employee support. Then ask which party handles each charge and whether prices can change during the term.

Which model fits your company?

PEPM may fit a broad benefit with predictable census-based budgeting. Active-participant pricing may fit a pilot or a program where the employer wants fees to follow actual enrollment. The right answer depends on scope, participation and administration—not just the rate.

Use the GLP-1 cost per employee guide for more examples, open the ROI calculator to model active participants, and request a proposal for a scope-specific conversation.

This article is educational and is not financial, tax, legal or medical advice.

Sources

Menopause weight gain has a cause — and a protocol.

The metabolic slowdown of menopause is driven by estrogen-related insulin resistance, cortisol, and muscle loss. The kindr Metabolic Reset addresses all three.

See the Metabolic Reset →On a GLP-1? Start here →
Prescription weight care → talk to a physician

Medically reviewed by Kindr Health Clinical Team
Last updated: November 15, 2026

Continue across the Kindr entity graph

Related evidence, peptides, and clinical tools on the same topic.

This content is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Keep reading

Research

Hormone therapy dispensing has more than doubled: what the new JAMA data mean for you

A new JAMA analysis of pharmacy dispensing, as reported by Science News, finds monthly hormone therapy dispensing to women aged 40 to 74 more than doubled since 2023, with growth in transdermal and vaginal estrogen while pills stayed flat, and we look at what that means for planning care

Research

Menopause equity: why so many women still fall through the cracks, and how to get the care you deserve

An AMWA position paper names gaps that still keep people from menopause care: training, screening, coverage, research and stigma. We look at what's changing in state law, a new academic post in British Columbia, and ACOG's guidance, and we offer a practical checklist for getting evaluated.

Research

Menopause care is going mainstream in state law: what's changing on coverage, education and work

Statehouses are moving on menopause coverage, education and work: what Illinois has enacted, what is pending in Pennsylvania, and what to ask your insurer. A federal survey also shows how few symptomatic women ages 40 to 60 currently take a prescription, and we look at how ACOG's new guidance fits in.

Explore your next step

Kindr Care is being updated, and the exact clinical process will depend on the current care pathway.

Explore care options →